XML 27 R70.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed consolidating guarantor financial information - Income and Comprehensive Income (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 29, 2019
Jun. 30, 2019
Mar. 31, 2019
Sep. 30, 2018
Jul. 01, 2018
Apr. 01, 2018
Sep. 29, 2019
Sep. 30, 2018
Condensed Income Statements, Captions [Line Items]                
Net revenues $ 648,319     $ 609,672     $ 1,914,410 $ 1,806,768
Cost of goods sold 272,639     267,099     821,064 788,147
Gross profit 375,680     342,573     1,093,346 1,018,621
Selling, general and administrative expenses 229,896     214,894     693,775 660,148
Research and development expenses 27,984     26,365     82,729 78,410
Restructuring and impairment charges 1,268     19,209     20,348 77,625
Gain on sale of assets (1,089)     0     (3,828) 0
Income from continuing operations before interest and taxes 117,621     82,105     300,322 202,438
Interest, net 19,075     26,851     61,714 78,987
Income from continuing operations before taxes 98,546     55,254     238,608 123,451
(Benefit) taxes on income from continuing operations (130,383)     (1,286)     (115,567) 14,532
Equity in net income of consolidated subsidiaries 0     0     0 0
Income from continuing operations 228,929     56,540     354,175 108,919
Operating (loss) income from discontinued operations (9)     (83)     (1,291) 1,246
Tax benefit on operating income (loss) from discontinued operations (9)     (67)     (317) (47)
Loss from discontinued operations 0     (16)     (974) 1,293
Net income 228,929 $ 83,375 $ 40,897 56,524 $ (2,496) $ 56,184 353,201 110,212
Other comprehensive loss (38,594)     17,253     (23,416) (24,076)
Comprehensive income 190,335     73,777     329,785 86,136
Eliminations                
Condensed Income Statements, Captions [Line Items]                
Net revenues (140,323)     (111,299)     (377,453) (331,214)
Cost of goods sold (129,917)     (111,411)     (359,945) (324,994)
Gross profit (10,406)     112     (17,508) (6,220)
Selling, general and administrative expenses (497)     (22)     (405) (352)
Research and development expenses 0     0     0 0
Restructuring and impairment charges 0     0     0 0
Gain on sale of assets 0           0  
Income from continuing operations before interest and taxes (9,909)     134     (17,103) (5,868)
Interest, net 0     0     0 0
Income from continuing operations before taxes (9,909)     134     (17,103) (5,868)
(Benefit) taxes on income from continuing operations (1,824)     13     (3,057) (1,090)
Equity in net income of consolidated subsidiaries (485,805)     (137,197)     (748,631) (312,943)
Income from continuing operations (493,890)     (137,076)     (762,677) (317,721)
Operating (loss) income from discontinued operations 0     0     0 0
Tax benefit on operating income (loss) from discontinued operations 0     0     0 0
Loss from discontinued operations 0     0     0 0
Net income (493,890)     (137,076)     (762,677) (317,721)
Other comprehensive loss 121,877     (31,054)     91,808 57,242
Comprehensive income (372,013)     (168,130)     (670,869) (260,479)
Parent Company                
Condensed Income Statements, Captions [Line Items]                
Net revenues 0     0     0 0
Cost of goods sold 0     0     0 0
Gross profit 0     0     0 0
Selling, general and administrative expenses 14,919     11,347     45,398 32,958
Research and development expenses 334     378     1,414 1,094
Restructuring and impairment charges 0     0     0 0
Gain on sale of assets 0           0  
Income from continuing operations before interest and taxes (15,253)     (11,725)     (46,812) (34,052)
Interest, net 25,367     25,191     58,782 72,120
Income from continuing operations before taxes (40,620)     (36,916)     (105,594) (106,172)
(Benefit) taxes on income from continuing operations (13,374)     (13,449)     (41,765) (39,859)
Equity in net income of consolidated subsidiaries 256,175     80,007     418,004 176,511
Income from continuing operations 228,929     56,540     354,175 110,198
Operating (loss) income from discontinued operations (9)     (83)     (1,291) (33)
Tax benefit on operating income (loss) from discontinued operations (9)     (67)     (317) (47)
Loss from discontinued operations 0     (16)     (974) 14
Net income 228,929     56,524     353,201 110,212
Other comprehensive loss (38,594)     17,253     (23,416) (24,076)
Comprehensive income 190,335     73,777     329,785 86,136
Guarantor Subsidiaries                
Condensed Income Statements, Captions [Line Items]                
Net revenues 449,753     398,961     1,304,385 1,169,684
Cost of goods sold 290,466     232,209     769,639 681,300
Gross profit 159,287     166,752     534,746 488,384
Selling, general and administrative expenses 140,053     130,769     413,380 400,987
Research and development expenses 20,321     19,482     60,773 57,668
Restructuring and impairment charges 661     17,128     6,742 20,581
Gain on sale of assets 0           0  
Income from continuing operations before interest and taxes (1,748)     (627)     53,851 9,148
Interest, net (20,911)     (15,391)     (42,756) (41,406)
Income from continuing operations before taxes 19,163     14,764     96,607 50,554
(Benefit) taxes on income from continuing operations 4,393     1,765     31,643 23,233
Equity in net income of consolidated subsidiaries 229,630     56,818     330,627 135,425
Income from continuing operations 244,400     69,817     395,591 162,746
Operating (loss) income from discontinued operations 0     0     0 0
Tax benefit on operating income (loss) from discontinued operations 0     0     0 0
Loss from discontinued operations 0     0     0 0
Net income 244,400     69,817     395,591 162,746
Other comprehensive loss (58,995)     14,107     (43,389) (30,691)
Comprehensive income 185,405     83,924     352,202 132,055
Non-Guarantor Subsidiaries                
Condensed Income Statements, Captions [Line Items]                
Net revenues 338,889     322,010     987,478 968,298
Cost of goods sold 112,090     146,301     411,370 431,841
Gross profit 226,799     175,709     576,108 536,457
Selling, general and administrative expenses 75,421     72,800     235,402 226,555
Research and development expenses 7,329     6,505     20,542 19,648
Restructuring and impairment charges 607     2,081     13,606 57,044
Gain on sale of assets (1,089)           (3,828)  
Income from continuing operations before interest and taxes 144,531     94,323     310,386 233,210
Interest, net 14,619     17,051     45,688 48,273
Income from continuing operations before taxes 129,912     77,272     264,698 184,937
(Benefit) taxes on income from continuing operations (119,578)     10,385     (102,388) 32,248
Equity in net income of consolidated subsidiaries 0     372     0 1,007
Income from continuing operations 249,490     67,259     367,086 153,696
Operating (loss) income from discontinued operations 0     0     0 1,279
Tax benefit on operating income (loss) from discontinued operations 0     0     0 0
Loss from discontinued operations 0     0     0 1,279
Net income 249,490     67,259     367,086 154,975
Other comprehensive loss (62,882)     16,947     (48,419) (26,551)
Comprehensive income $ 186,608     $ 84,206     $ 318,667 $ 128,424